Fast access to testosterone therapy for transgender adults is “life-saving”, leading to a significantly reduced risk of depression and suicide, a clinical trial led by the University of Melbourne has found.
It is the world’s first study to examine the impact of access to hormone therapy on mental distress for trans people through a randomised control trial, a strong type of study crucial in medicine due to the minimal risk of confounding factors influencing the results.
.jpg?w=600)
